Artery Research
Volume 3, Issue 4 , Pages 125-127 , December 2009

Central blood pressure: A new vital sign?

  • Mary J. Roman

      Affiliations

    • Corresponding Author InformationTel.: +1 212 746 4685; fax: +1 212 746 8561.

References 

  1. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416
  2. Kelly R, Hayward C, Ganis J, Daley J, Avolio A, O'Rourke M. Noninvasive registration of the arterial pressure waveform using high-fidelity applanation tonometry. J Vasc Med Biol. 1989;1:142–149
  3. Chen C-H, Ting CT, Nussbacher A, Nevo E, Kass DA, Pak P, et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27:168–175
  4. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932–937
  5. Siebenhofer A, Kemp CRW, Sutton AJ, Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens. 1999;13:625–629
  6. Lane D, Beevers M, Barnes N, Bourne J, John A, Malins S, et al. Inter-arm differences in blood pressure: when are they clinically significant?. J Hypertens. 2002;20:1089–1095
  7. Lee ET, Welty TK, Fabsitz RR, Cowan LD, Lee N-A, Oopik AJ, et al. The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132:1141–1155
  8. Fox CS, Coady S, Sorlie PD, D'Agostino RB, Pencina MJ, Ramachandran RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115:1544–1550
  9. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197–203
  10. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J Hypertens, in press.
  11. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, et al. Normalization for body size and the population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens. 2005;18:191–196
  12. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056–1062
  13. Chen C-H, Ting C-T, Lin S-J, His T-L, Ho S-J, Chou P, et al. Which arterial and cardiac parameters best predict left ventricular mass?. Circulation. 1998;98:422–428
  14. Flack JM, Gardin JM, Yunis C for the CARDIA Research Group. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the Cardia Study. Am Heart J. 1999;138:856–864
  15. Verdecchia P, Schillaci G, Borgioni C, Gaatobigio R, Ambrosio G, Porcellati C. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension. Eur Heart J. 2002;23:658–665
  16. Wang K-L, Cheng H-M, Chuang S-Y, Spurgeon HA, Ting C-T, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?. J Hypertens. 2009;27:461–467
  17. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol. 2008;51:2432–2439
  18. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol. 2009;54:1730–1734Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W. High central pulse pressure is independently associated with adverse cardiovascular outcome: the Strong Heart Study. J Am Coll Cardiol, 2009; 54:1730--4.
  19. De Luca N, Asmar RG, London GM, O'Rourke MF, Safar  on behalf of the REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623–1630
  20. Poulter NR, Weddel H, Dahlof B, Sever PS, Beevers DG, Caulfield M, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA). Lancet. 2005;366:907–913
  21. The CAFÉ Investigators  for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFÉ) study. Circulation. 2006;113:1213–1225
  22. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995–1003
  23. McEniery CBM, Yasmin McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. on Behalf of the Anglo-Cardiff Collaborative Trial Investigators Central pressure: variability and impact of cardiovascular risk factors: the anglo-cardiff collaborative trial II. Hypertension. 2008;51:1476–1482

PII: S1872-9312(09)00270-1

doi: 10.1016/j.artres.2009.10.179

Artery Research
Volume 3, Issue 4 , Pages 125-127 , December 2009

Article Tools